PMID- 33748274 OWN - NLM STAT- MEDLINE DCOM- 20210525 LR - 20210525 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2021 DP - 2021 TI - Correlation between TNF-alpha -308 and +489 Gene Polymorphism and Acute Exacerbation of Chronic Obstructive Pulmonary Diseases. PG - 6661281 LID - 10.1155/2021/6661281 [doi] LID - 6661281 AB - Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is becoming a common respiratory disease, leading to increased morbidity and mortality worldwide. Tumor necrosis factor-alpha (TNF-alpha) is a powerful proinflammatory cytokine involved in the pathogenesis of AECOPD. Therefore, we proposed a close correlation between the TNF-alpha polymorphism [-308G/A (rs1800629), +489G/A (rs1800610)] and the disease progress of patients with AECOPD. Comparison of the TNF-alpha genotypes between the 198 AECOPD diagnosed patients groups and 195 healthy peoples suggested their significant differences of the three genotypes (AA, GA, GG) distribution for TNF-alpha -308 (P < 0.05), but no differences of that for TNF-alpha +489. We found that patients with TNF-alpha -308 GA/AA genotypes showed smaller adjacent arterial diameter, thicker bronchial wall, higher bronchial artery ratio, higher bronchial wall grading, and higher frequency of acute exacerbations than those with TNF-alpha -308 GG genotype. Patients with TNF-alpha +489 GA/AA genotypes showed the same AECOPD properties as patients with TNF-alpha -308 except for the high frequency of acute exacerbations. Further experiment showed that the TNF-alpha -308 and+489 gene polymorphisms could affect the expression level of TNF-alpha in macrophages, suggesting the involvement of the macrophage population in disease regulation of AECOPD patients with TNF-alpha -308G/A and+489G/A genotype heterogeneity. In conclusion, the TNF-alpha -308 G/A genotype was related to AECOPD susceptibility and progress, while the TNF-alpha +489G/A genotype was related to AECOPD progress, but not AECOPD susceptibility. CI - Copyright (c) 2021 Suyun Yu et al. FAU - Yu, Suyun AU - Yu S AUID- ORCID: 0000-0003-4351-4899 AD - Department of Respiratory, Minhang Hospital, Fudan University, Shanghai 201199, China. FAU - Xue, Min AU - Xue M AUID- ORCID: 0000-0002-5763-6339 AD - Department of Respiratory, Minhang Hospital, Fudan University, Shanghai 201199, China. FAU - Yan, Zhijun AU - Yan Z AUID- ORCID: 0000-0001-8945-5463 AD - Department of Respiratory, Minhang Hospital, Fudan University, Shanghai 201199, China. FAU - Song, Bin AU - Song B AUID- ORCID: 0000-0001-8493-2523 AD - Department of Radiology, Minhang Hospital, Fudan University, Shanghai 201199, China. FAU - Hong, Haiping AU - Hong H AUID- ORCID: 0000-0003-4678-566X AD - Shanghai Songjiang District Fangta Hospital of Traditional Chinese Medicine, Shanghai 201699, China. FAU - Gao, Xiwen AU - Gao X AUID- ORCID: 0000-0003-1437-4866 AD - Department of Respiratory, Minhang Hospital, Fudan University, Shanghai 201199, China. LA - eng PT - Clinical Trial PT - Journal Article DEP - 20210301 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Aged MH - Aged, 80 and over MH - Female MH - *Gene Expression Regulation MH - *Genotype MH - Humans MH - Macrophages/metabolism/pathology MH - Male MH - *Polymorphism, Genetic MH - *Pulmonary Disease, Chronic Obstructive/genetics/metabolism/pathology MH - *Tumor Necrosis Factor-alpha/biosynthesis/genetics PMC - PMC7943264 COIS- The authors declare that they have no conflicts of interest. EDAT- 2021/03/23 06:00 MHDA- 2021/05/26 06:00 PMCR- 2021/03/01 CRDT- 2021/03/22 08:23 PHST- 2020/12/24 00:00 [received] PHST- 2021/02/05 00:00 [revised] PHST- 2021/02/22 00:00 [accepted] PHST- 2021/03/22 08:23 [entrez] PHST- 2021/03/23 06:00 [pubmed] PHST- 2021/05/26 06:00 [medline] PHST- 2021/03/01 00:00 [pmc-release] AID - 10.1155/2021/6661281 [doi] PST - epublish SO - Biomed Res Int. 2021 Mar 1;2021:6661281. doi: 10.1155/2021/6661281. eCollection 2021.